The authors demonstrated that 3TSR sensitized GBM lines to caspase-3/7-mediated apoptosis by upregulating tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor DR4/5 expression in a CD36-dependent manner. The gene discussed is CD36; the disease is glioblastoma.